Sort
38,696 grants matching “als”
Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies
$5,909,857Carsten Bãnnemann · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
MRI Evaluation Of Acute Cardiovascular Disease
$5,822,093Andrew Arai · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimer's Disease
$5,774,586Anthony O Caggiano · Cognition Therapeutics, Inc. · R01 · FY2020 · AG
A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimer's Disease
$5,735,586Susan M Catalano · Cognition Therapeutics, Inc. · R01 · FY2019 · AG
Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS)
$5,712,981Bjorn E Oskarsson · Mayo Clinic Jacksonville · U01 · FY2025 · NS
MRI Evaluation Of Acute Cardiovascular Disease
$5,654,944Andrew Arai · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
CLARITY: fully-assembled biology
$5,649,751Karl Alexander Deisseroth · Stanford University · R01 · FY2012 · MH
Integrative genetics of behavior with high throughput technologies
$5,648,001David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$5,627,958Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Integrative genetics of behavior with high throughput technologies
$5,607,530David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA
Neuropathogenesis of Retroviral Infections
$5,580,007Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Neuropathogenesis of Retroviral Infections
$5,580,007Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
$5,508,768Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Platform technologies for scalable highly multiplexed proteomic phenotyping of the brain
$5,474,824Peng Yin · Harvard University · RF1 · FY2021 · MH
Pharmacokinetics and Drug Metabolism
$5,444,464Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
$5,420,959Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA
$5,397,843Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Neuropathogenesis of Retroviral Infections
$5,346,668Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Multimodal MRI in Multiple Sclerosis
$5,306,685Daniel Reich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before
$5,302,032Yael Emilie Bensoussan · University Of South Florida · OT2 · FY2023 · OD
Glial regulation of ER stress resistance
$5,279,553Ashley Frakes · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Integrative genetics of behavior with high throughput technologies
$5,274,705David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
Neuropathogenesis of Retroviral Infections
$5,206,475Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS
$5,159,965Neil Alan Shneider · Columbia University Health Sciences · U01 · FY2024 · NS
Search for the Structural Basis of Biomacromolecular Function and Activity
$5,154,622Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA